Effect of Allopurinol on renal residual function

Study of the effect of Allopurinol on renal residual function in hyperuricemic peritoneal dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20090905002417N20

Enrollment

Registered

2018-03-21

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

end stage renal disease. end stage renal disease

Interventions

Intervention 1: Intervention group: Allopurinol tablet usage, 100mg daily orally for 6 months manufactured by Jalinous company. Intervention 2: Control group: no drug use.

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: consent for cooperation peritoneal dialysis for at least 3 months 18-80 years old hyperuricemia: uric acid level =7mg/dL in men and =6mg/dL in women minimum residual renal function : 2cc/min/m2

Exclusion criteria

Exclusion criteria: death allopurional allergy or complications hemodialysis rout for dialysis renal transplantation nephrotoxic drug use

Design outcomes

Primary

Measure	Time frame
Serum uric acid level. Timepoint: before intervention and 6 months after drug use. Method of measurement: laboratory kit- ELISA- with HITACHI equipment.;Residual renal function. Timepoint: before intervention and 6 months after drug use. Method of measurement: renal function formula.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Elham kabiri

Esfahan University of Medical Sciences

Kabirielham20@gmail.com+98 31 3668 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026